Investors and Media

Press Releases

August 8, 2018

Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress

August 2, 2018

Scholar Rock to Participate in Upcoming Investor Conferences

June 4, 2018

Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering

May 31, 2018

Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015

May 23, 2018

Scholar Rock Announces Pricing of Initial Public Offering

April 9, 2018

Scholar Rock Appoints Rhonda Chicko as Chief Financial Officer

March 29, 2018

Scholar Rock Granted Orphan Drug Designation by the FDA for SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

February 2, 2018

Scholar Rock Announces Publication of Comprehensive Pharmacological Study of SRK-015, a Novel Inhibitor of Myostatin Activation, Supporting the Treatment of Muscle Atrophy Disorders

Archived Press Releases